Updated Analyses: Safety and Efficacy of Gemtuzumab Ozogamicin and Venetoclax in Patients with Relapsed or Refractory CD33+ Acute Myeloid Leukemia: A Phase Ib/II Study

Updated Analyses: Safety and Efficacy of Gemtuzumab Ozogamicin and Venetoclax in Patients with Relapsed or Refractory CD33+ Acute Myeloid Leukemia: A Phase Ib/II Study

Saved in:
Bibliographic Details
Published in:Blood Vol. 140; no. Supplement 1; pp. 11725 - 11726
Main Authors: Arain, Saad, Avila, Ana Maria, Christian, Sonia, Patel, Pritesh, Sweiss, Karen, Parkin, Brian, Saraf, Santosh L., Rubinstein, Paul G., Calip, Gregory S, Quigley, John G.
Format: Journal Article
Language:English
Published: Elsevier Inc 15-11-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-165615